2018
Consulter
2020
Several concepts, which in the aggregate get might be used to account for "resilience" against age- and disease-related changes, have (…)
Consulter
2018
To estimate the prevalence of amyloid positivity, defined by positron emission tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological examination, in (…)
Consulter
2018
In Alzheimer’s disease (AD), pathological changes may arise up to 20 years before the onset of dementia. This pre-dementia window provides (…)
Consulter
2019
Alzheimer’s disease and related dementias (ADRDs) are a global crisis facing the aging population and society as a whole. With (…)
Consulter
2019
Amnestic mild cognitive impairment (aMCI) is a clinical entity with various potential etiologies including but not limited to Alzheimer’s disease. (…)
Consulter